SCHEMBL31228193

SCHEMBL31228193

C#CC1(O)C(n2cc(C(N)=O)c3c(N)ncnc32)OC(F)(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C1O

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 5/20 0.41
▸ P2RY2 P41231 4/20 0.41
▸ P2RY11 Q96G91 2/20 0.41
▸ ADK P55263 2/20 0.39
▸ P2RX1 P51575 6/20 0.36
▸ P2RX3 P56373 6/20 0.36
▸ P2RX2 Q9UBL9 4/20 0.36
▸ P2RX4 Q99571 5/20 0.36
▸ POLRMT O00411 1/20 0.35
▸ RNASEL Q05823 1/20 0.34
▸ P2RX7 Q99572 2/20 0.34
▸ SRC P12931 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ P2RX6 O15547 1/20 0.34
▸ P2RX5 Q93086 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21078478 1.00 P2RY1 (0.41) P2RY1P2RY2P2RY11ADKP2RX1
SCHEMBL21078481 0.91 P2RY1 (0.42) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL31228238 0.91 P2RY1 (0.42) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL31228114 0.89 P2RY1 (0.40) P2RY1P2RY2P2RY11ADKP2RX1
SCHEMBL21078480 0.89 P2RY1 (0.40) P2RY1P2RY2P2RY11ADKP2RX1
SCHEMBL21078488 0.84 P2RY1 (0.56) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL19859787 0.84 ADK (0.46) ADKSRCALDH1A1
SCHEMBL21078516 0.84 P2RY1 (0.42) P2RY1P2RY2P2RY11ADKP2RX1
SCHEMBL31228569 0.84 P2RY1 (0.42) P2RY1P2RY2P2RY11ADKP2RX1
SCHEMBL16575842 0.78 POLG (0.41) P2RY1P2RY2P2RY11P2RX1P2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP claimed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO claimed
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP disclosed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO disclosed
Send feedback